DOCSLIB.ORG

Cphi & P-MEC China Exhibition List展商名单version版本20180307

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

CPhI & P-MEC China Exhibition List展商名单 Version版本 20180307 Booth/ Company Name/公司中英文名 Product/产品 展位号 Aarti Drugs Limited E1A01 IPTG,EDAC HCl,2-脱氧-D-核糖IPTG,EDAC HCl,2-deoxy-D-ribose Analytical standards,Natural products,Amino acids and peptides,Steroids,API’s, impurities, and metabolites,Stable isotope labelled analogues,Building blocks,Chiral molecules,Carbohydrates and oligosaccharides,Nucleic acid derivatives,Enzyme Abiquifi E1A08 activators and inhibitors,Sulfhydryl active agents,Fluorescent reagents,Spin labels,Nicotine derivatives and metabolites,Neurochemicals,Environmental standards,mutagens, and metabolites,Phthalates,Retinoids,Vitamin D derivatives,Drugs of abuse for forensic testing,Phosphates SiliaMetS,SiliaCat,SiliaFlash,SiliaBond,Metal Scavenger,Catalyst,silica Agno Pharma E1A10 gel,chromatographic phases Alchem International Pvt Ltd E1A11 铝,包装,瓶,原料药Aluminum,Bottle,Packaging,API 紫杉醇,多西他赛,秋水仙碱,利血平,硫秋水仙碱苷,欧洲越橘,葡萄籽,银杏叶,姜黄,橄榄果,绿茶,水飞 蓟,乳香,锯叶棕,积雪草Paclitaxel,Docetaxel, Alkaloids Corporation E1A17 Colchicine,Reserpine,Thiocolchicoside,Bilberry,Grape Seed,Ginkgo Biloba,Curcumin,Olive,Green Tea, Silymarin, Boswellia,Saw Palmetto,Centella Asiatica ALT Laboratory Limited/ALT 制药有限公司 E1A19 Amano Enzyme China Ltd E1A21 Amarantine Pharmaceutical LLC E1A25 AMRI E1A31 Angelini A.C.R.A.F SPA E1A32 BROMOBENZENE,N PROPYL BROMIDE,SODIUM BROMIDE,ETHYL Anuh Pharma E1A51 BROMIDEBROMOBENZENE,NPROPYL BROMIDE,SODIUM BROMIDE,ETHYL BROMIDE APC Pharmaceutical & Chemical Ltd E1B01 APEX HEALTHCARE LIMITED E1B09 Tacrolimus,Mycophenolate Mofetil,Mycophenolate Sodium,Cyclosporine,Sirolimus,Pimecrolimus,Temsirolimus,Everolimus,Romidepsin,Mitomyci Asahi Glassplant E1B10 n,Dactinomycin,Teicoplanin,Fidaxomicin,Mupirocin,Mupirocin Calcium,Anidulafungin,Micafungin Sodium,Milbemycin Oxime,Daptomycin,Retapamulin,Doxorubicin,Epirubicin,Bleomycin,Dalbavancin Abiraterone acetate,Anastrozole,Apixaban,Apremilast,Atazanavir sulfate,Azacitidine,Benazepril hydrochloride,Bimatoprost,Bivalirudin,Bortezomib,Capecitabine,Celecoxib,Cladribine,Da ATS Engineering Limited/ATS安拓思纳米技术（苏 ntrolene sodium,Decitabine,Desmopressin acetate,Docetaxel anhydrous,Docetaxel E1B11 州）有限公司 trihydrate,Entecavir,Enzalutamide,Everolimus,Exemestane,Flumazenil,Fluticasone propionate,Fulvestrant,Galantamine,Galantamine hydrobromide,Gefitinib,Gemcitabine hydrochloride,Granisetron hydrochloride,Ibrutinib,Irinotecan hydrochloride,Lapatinib ditosylate,Letrozole,Octreotide acetate,Omeprazole,Ondansetron Leuprolide acetate depot injection,Cross-linked hyaluronic acid filler,Propofol injection,Daptomycin,Teicoplanin,Alprostadil injection,Octreotide LAR AVA GmbH u. Co. KG E1B19 injection,Liposomal amphotericin B injection,DOTA,Iopamidol,Gadopentetate meglumine,Entecavir depot injection,Teriparatide acetate injection,Donepezil depot injection Bachem AG E1B22 吡混,呋辛,西丁Cefepime ,Cefuroxime,Cefoxitin Bioiberica S.A.U. E1B25 Boehringer Ingelheim Biopharmaceuticals E1B28 IDL GmbH 地高辛,丁溴东莨菪碱,甲基硫酸新斯的明,5-氟尿嘧啶Digoxin,Hyoscine Bolon Pharmachem Co., Ltd. E1B31 Butylbromide,Neostigmine Methylsulfate,5-Fluorouracil Bormioli Pharma S.r.l. E1B32 Brenntag E1B35 Buchi Reactor Systems & Pilot Plants E1B51 CARBOGEN AMCIS AG E1C21 Active Pharmaceutical Ingredients,Intermediates,Excipients and Drug Formulation Carbosynth Ltd E1C25 Changsung Softgel System Ltd. E1C31 RLDs Chemclone Industries E1C32 原料药,中间体,生化药剂,营养补充剂APIs,Intermediates,Biochemicals,Nutritional Supplements Chemcon Speciality Chemicals Private Limited E1C51 Parteck®SRP 80,Parteck®MXP,Parteck®Delta 甘露醇 Chempro Pharma PVT LTD E1C57 托品醇,去甲托品醇,托品酮,托品酸tropanes series,tropine,nortropine Chemsphere Technology Inc. E1D01 Chemwerth Inc. E1D02 对氨基三氟甲氧基苯,2,6-二溴-4-三氟甲氧基苯胺,对三氟甲氧基苯酚,4-三氟甲氧基苯基异氰酸酯,间 三氟甲基苯甲酸甲酯,2-氯-5-氨基三氟甲苯 ,4-三氟甲基苯甲醛,2,6-二氟-4-溴三氟甲氧基苯,2-溴-4- 甲基苯酚,4,4\'\'-二溴-p-三联苯,全氟丁醇,全氟丁酸,全氟丁基磺酰氟,五氟苯酚,茚满,氟化氢三乙 胺,2-氟丙二酸二乙酯,5-三氟甲基尿嘧啶4-Trifluoromethoxy aniline,2,6-Dibromo-4- China Chinopharma Ltd. E1D10 trifluoromethoxyaniline,4-Trifluoromethoxy phenol,4-(Trifluoromethoxy) phenyl isocyanate,Methyl 3-(trifluoromethyl) benzoate,5-Amino-2-chlorobenzotrifluoride,4- Trifluoromethyl benzaldehyde,2,6-Difluoro-4-bromo(trifluoromethoxy)benzene,2-Bromo-4- methylphenol,4,4’’-dibromo-p-terphenyl,2,2,3,3,4,4,4- Ovolecithin(DS-PL95E),Soy Lecithin(DS-Soya series),Ceramide(DS-Cera series),Egg Chiral Quest (Suzhou) Co., Ltd E1D22 Lecithin(DS-PL series) Chirogate International Inc. E1D25 Dacarbazine Chunghwa Chemical Synthesis & Biotech Co., E1D26 cyclen,fosinopril inter,trimebutine,Fulvestrant,2-Methoxyethylamine,Glatiramer,cyclam Ltd. Cilicant Chem Private Limited E1D27 美洛培南,厄他培南,柳菩林,特立帕肽Meropenem,Ertapenem,Leuprolide,Teriparatide Concord Biotech Limited E1D31 Corel Pharma Chem E1D57 Albendazole,Alfuzosin HCl,Ambroxol HCl,Amoxicillin Trihydrate,Analgin ,Metamizol Sodium,Atorvastatine,Atorvastatine Calcium,Azelaic Acid,Bacitracin Zinc,Bisoprolol Hemifumarate,Budesonide,Caffeine,Captopril,Carbamazepine,Chlorzoxazone,Ciproflox acin Base,Ciprofloxacin HCl,Cisplatin,Clarithromycin,Clopidogrel Form I,Colistin Council of Euope - EDQM E1E01 Sulphate,Dehydrocholic Acid,Dextromethorphan Hydrobromide,Diacerein,Diclofenac Sodium,Dihydrocodeine Bitartrate,Diltiazem HCl,Doxycycline Hyclate,Enrofloxacin,Erythromycin Base,Erythromycin Stearate,Estramustine Sodium Phosphate,Ethion,Famotidine,Fentanyl Citrate,Florfenicol,Fluticasone Acetate,Fluticasone 三氮脒,克洛索隆,硝碘酚腈,布帕伐醌,硝唑尼特Diminazene Diaceturate,Clorsulon,Buparvaquone,Toldimfos Sodium,Triclabendazole,Praziquentel,Flunixin Meglumine,Imidocarb CUBE E1E24 Dipropioinate,Nitroxynil,Parvaquone,Butaphosphan,Bithionol Sulfoxide,S- Methoprene,Nitazoxanide,Ranolazine,Febuxostat,Atovovquone,Homidium Tabs,Diminazene Sachets Dah Feng Capsule Industry Co., Ltd E1E25 Butylscopolamine,Vincamine,Vinpocetine,5-HTP,Bilberry,Ginkgo,MedCan,HMRlignan,Red DCS Pharma AG E1E26 clover,NioSkin,SylTech 米索前列醇-羥丙基甲基纖維素1%,前列地爾,依前列醇鈉,利马前列素阿法环糊精,鲁比前列酮,拉坦前 列素,貝美前列素,曲伏前列素,曲前列尼爾,非洛地平,甲磺酸雷西吉蘭,硼替佐米,吉非替尼,芬戈莫德, Dipharma Francis S.r.l E1E27 納呋拉啡,氯前列醇鈉Misoprostol-HPMC,Alprostadil,Epoprostenol Sodium,Limaprost alfadex,Lubiprostone,Latanoprost,Bimatoprost,Travoprost,Treprostinil,Felodipine,Rasagilin e Mesylate,Bortezomib,Gefitinib,Fingolimod HCL,Nalfurafine HCL,Cloprostenol Sodium Divi's Laboratories Limited E1E28 Atorvastatin,Pregabalin,Sitagliptin,Olmesartan,Etodolac,Gliclazide,Bosentan,Voglibose,Li maprost,Bimaprost,Beraprost,Lubiprostone,Treprostinil,Dronedarone,Telmisartan,Furosemi DOCKWEILER AG E1F01 de,Duloxetine,Gabapentin,Abiraterone,Efavirenz,Posaconazole,Efinaconazole,Tenofovir, Montelucast,Phenibut,Propranolol,Travoprost,Dinoprostone Dongkook Pharmaceutical Co., Ltd. E1F03 Pharmaceutical Services Doosan Corporation E1F10 Pheniramine Maleate,Brompheniramine Maleate,Salbutamol Sulphate,Cetirizine Di HCl ELBI Pharmaceuticals Wholesale E1F22 APIs,Intermediates 高纯度活化PEG,高纯度吐温80,高纯度磷脂Activated- Espee Group Innovators E1F24 PEG,Polysorbate80,Phospholipid,Polysorbate20 Everlight Chemical Industrial Corporation E1F26 扑热息痛,阿司匹林,水杨酸甲酯,水杨酸,水杨酸辛酯,胡莫柳酯,烯丙醇,对氨基苯酚,碳酸氢钠,异丙醇, 苯乙酮Paracetamol,Aspirin,Methyl Salicylate,Salicylic Acid,Octyl F.I.S. Fabbrica Italiana Sintetici SpA E1F28 Salicylate,Homosalate,Allyl Alcohol,Para amino phenol,Sodium Bicarbonate,Isopropanol,Acetophenone Farmak a.s. E1F32 COMPLIANCE,MARKET ACCESS & SUPPLY CHAIN,PROJECT MANAGEMENT,GDP Finar Limited E1F35 Atosiban,Desmopressin,Goserelin,Triptorelin acetate Fischer Chemicals AG E1F51 氯前列醇钠cloprostenol sodium FMC Corporation E1F55 Azacitidine for injection,Pemetrexed disodium for injection,Bortezomib for injection,Voriconazole for injection ,Alprostadil for injection,Azacitidine,Bortezomib,Pemetrexed disodium FMC Corporation E1F57a ,Paclitaxel,Docetaxel,Sulfamethoxazole sodium,Mesulphen,Astaxanthin,Chitosan Oligosaccharide Lactate,Alfa-Calcidol,Calcifediol,Ergocalciferol,γ-PGA,CMO/CRO Service,Quality Consistency Evaluation for Generic Drugs Fuji Silysia Chemical SA E1F57b Genovior Biotech Corporation E1G51 锂化学品,有机金属化合物,丁基锂Lithium,Organometallics,Butyllithium GfM mbH E1G53 Thiocolchicoside,Colchicine,Reserpine,Yohimbine, Deacetyl Baccatine III (10-DAB III),Paclitaxel,Docetaxel,Raubasine,Garcenia Combogia,Gymnema Granules India Ltd E1G57 SylvestreThiocolchicoside,Colchicine,Reserpine,Yohimbine, Deacetyl Baccatine III (10- DAB III),Paclitaxel,Docetaxel,Raubasine,Garcenia Combogia,Gymnema Sylvestre 抗病毒类、抗肿瘤类、抗感染类和甾体类中间体、原料药和药物制剂及医药合约研发和加工服务 APIs and Finished products of ARV, Oncology, Anti-infection and Hormone drugs and HARMAN FINOCHEM E1H01 pharmaceutical CRO & CDMO service APIs and Finished products of ARV, Oncology, Anti-infection and Hormone drugs and pharmaceutical CRO & CDMO service 培他米松、地塞米松、泼尼松、泼尼松龙、甲泼尼龙、醋酸氢化可的松、螺内酯、氨基酸、GCLE 、7AVCA、头孢地尼、核黄素磷酸钠、甲睾酮、阿替洛尔、尼莫地平、阿加曲班、尼美舒利、阿 德福韦酯、注射用氢化可的松、注射用马来酸阿奇霉素、肝素钠注射液、注射用尿激酶、黄芪皂苷 I、II、III、番泻叶提取物、甜菊糖苷、萝卜硫素。Betamethasone Base, Dexamethasone Base, Hetero Labs Limited E1H16 Prednisone, Prednisolone, Methylprednisolone, Hydrocortisone Acetate, Spironolactone, Amino Acid, Budesonide, Fluocinolone Acetonide, Fluocinonide, Triamcinolone Base, Triamcinolone Acetonide, Halcinonide, Hydrocortisone Butyrate, GCLE, Cefidinir, 头孢克肟,头孢地尼,氧氟沙星,左氧氟沙星,盐酸环丙沙星,盐酸克林霉素,拉索拉唑,奥美沙坦,替米沙Biboflavin-5-Phosphate Sodium, Methyltestosterone, Atenolol, Nimodipine, Argatroban, 坦,UDCA,尼扎替丁,伊贝沙坦, 氟比洛芬, 洛索洛芬钠, 美索巴莫, 瑞巴派特, 盐酸金刚烷胺, 盐酸安非 他酮, 盐酸多奈哌齐, 加巴贲丁, 氟苯尼考, 碘海醇, 氯霉素, 中间体, 化工品Cefixime, Cefdinir, Ofloxacin, Levofloxacin, Ciprofloxacin HCl, Clindamycin Hydrochloride, Lansoprazole, High Science Co Ltd E1H20 Olmesartan, Telmisartan, UDCA, Nizatidine, Irbesartan, Flurbiprofen, Loxoprofen sodium, Methocarbamol, Rebamipide, Amantadine Hydrochloride,
Recommended publications
  • Pharmacological Investigations of Natural Β2-Adrenoceptors Agonists

    Pharmacological Investigations of Natural Β2-Adrenoceptors Agonists

    University of Szeged Faculty of Pharmacy Department of Pharmacodynamics and Biopharmacy Pharmacological investigations of natural β 2-adrenoceptors agonists on rat uterus in vitro and in silico studies Ph.D. Thesis By Aimun Abdelgaffar Elhassan Ahmed Pharmacist Supervisor Prof. Dr. George Falkay, Ph.D., D.Sc. Szeged, Hungary 2012 ~~xX ♥@ DEDICATION @♥Xx~~ @@@@@ I dedicate this work To my lovely parents, To my wife and kids To my brothers and sisters To all whom I love With my deepest love and Respect . ~~xX ♥@ Aimun @♥Xx~~ Publications list Publications related to the PhD thesis 1. Aimun Abdelgaffar Elhassan Ahmed , Robert Gaspar, Arpad Marki, Andrea Vasas, Mahmoud Mudawi Eltahir Mudawi, Judit Hohmann and George Falkay. Uterus-Relaxing Study of a Sudanese Herb (El-Hazha). American J. of Biochemistry and Biotechnology 6 (3): (2010) 231-238, ……... IF: 1.493 2. Aimun AE. Ahmed , Arpad Marki, Robert Gaspar, Andrea Vasas, Mahmoud M.E. Mudawi, Balázs Jójárt, Judit Verli, Judit Hohmann, and George Falkay. β2-Adrenergic activity of 6-methoxykaempferol-3-O-glucoside on rat uterus: in vitro and in silico studies. European Journal of Pharmacology 667 (2011) 348–354……………………..... IF: 2.737 3. Aimun AE. Ahmed , Arpad Marki, Robert Gaspar, Andrea Vasas, Mahmoud M.E. Mudawi, Balázs Jójárt, Renáta Minorics, Judit Hohmann, and George Falkay. In vitro and in silico pharmacological investigations of a natural alkaloid. Medicinal Chemistry Research, DOI:10.1007/s00044-011-9946-0,………….... IF: 1.058 Other publication Ahmed A EE , Eltyeb I B, Mohamed A H. Pharmacological activities of Mangifera indica Fruit Seed Methanolic Extract. Omdurman Journal of Pharmaceutical Sciences (2006), 1(2): 216-231, (Local Sudanese).
  • Supplementary Materials Evodiamine Inhibits Both Stem Cell and Non-Stem

    Supplementary Materials Evodiamine Inhibits Both Stem Cell and Non-Stem

    Supplementary materials Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70 Seung Yeob Hyun, Huong Thuy Le, Hye-Young Min, Honglan Pei, Yijae Lim, Injae Song, Yen T. K. Nguyen, Suckchang Hong, Byung Woo Han, Ho-Young Lee - 1 - Table S1. Short tandem repeat (STR) DNA profiles for human cancer cell lines used in this study. MDA-MB-231 Marker H1299 H460 A549 HCT116 (MDA231) Amelogenin XX XY XY XX XX D8S1179 10, 13 12 13, 14 10, 14, 15 13 D21S11 32.2 30 29 29, 30 30, 33.2 D7S820 10 9, 12 8, 11 11, 12 8 CSF1PO 12 11, 12 10, 12 7, 10 12, 13 D3S1358 17 15, 18 16 12, 16, 17 16 TH01 6, 9.3 9.3 8, 9.3 8, 9 7, 9.3 D13S317 12 13 11 10, 12 13 D16S539 12, 13 9 11, 12 11, 13 12 D2S1338 23, 24 17, 25 24 16 21 D19S433 14 14 13 11, 12 11, 14 vWA 16, 18 17 14 17, 22 15 TPOX 8 8 8, 11 8, 9 8, 9 D18S51 16 13, 15 14, 17 15, 17 11, 16 D5S818 11 9, 10 11 10, 11 12 FGA 20 21, 23 23 18, 23 22, 23 - 2 - Table S2. Antibodies used in this study. Catalogue Target Vendor Clone Dilution ratio Application1) Number 1:1000 (WB) ADI-SPA- 1:50 (IHC) HSP70 Enzo C92F3A-5 WB, IHC, IF, IP 810-F 1:50 (IF) 1 :1000 (IP) ADI-SPA- HSP90 Enzo 9D2 1:1000 WB 840-F 1:1000 (WB) Oct4 Abcam ab19857 WB, IF 1:100 (IF) Nanog Cell Signaling 4903S D73G4 1:1000 WB Sox2 Abcam ab97959 1:1000 WB ADI-SRA- Hop Enzo DS14F5 1:1000 WB 1500-F HIF-1α BD 610958 54/HIF-1α 1:1000 WB pAkt (S473) Cell Signaling 4060S D9E 1:1000 WB Akt Cell Signaling 9272S 1:1000 WB pMEK Cell Signaling 9121S 1:1000 WB (S217/221) MEK Cell Signaling 9122S 1:1000
  • WO 2012/044761 Al

    WO 2012/044761 Al

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date _ . 5 April 2012 (05.04.2012) WO 2012/044761 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 47/48 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, PCT/US201 1/053876 DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 29 September 201 1 (29.09.201 1) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, (26) Publication Langi English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (30) Priority Data: ZM, ZW. 12/893,344 29 September 2010 (29.09.2010) US (84) Designated States (unless otherwise indicated, for every (71) Applicant (for all designated States except US): UNI¬ kind of regional protection available): ARIPO (BW, GH, VERSITY OF NORTH CAROLINA AT WILMING¬ GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, TON [US/US]; 601 South College Road, Wilmington, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, NC 28403 (US).
  • Galeterone for the Treatment of Castration- Resistant Prostate Cancer Bruce Montgomery1, Mario A

    Galeterone for the Treatment of Castration- Resistant Prostate Cancer Bruce Montgomery1, Mario A

    Published OnlineFirst November 2, 2015; DOI: 10.1158/1078-0432.CCR-15-1432 Cancer Therapy: Clinical Clinical Cancer Research Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration- Resistant Prostate Cancer Bruce Montgomery1, Mario A. Eisenberger2, Matthew B. Rettig3, Franklin Chu4, Roberto Pili5, Joseph J. Stephenson6, Nicholas J. Vogelzang7, Alan J. Koletsky8, Luke T. Nordquist9, William J. Edenfield10, Khalid Mamlouk11, Karen J. Ferrante11, and Mary-Ellen Taplin12 Abstract Purpose: Galeterone is a selective, multitargeted agent that Results: In ARMOR1, across all doses, 49.0% (24/49) achieved a inhibits CYP17, antagonizes the androgen receptor (AR), and 30% decline in prostate-specific antigen (PSA; PSA30) and reduces AR expression in prostate cancer cells by causing an 22.4% (11/49) demonstrated a 50% PSA decline (PSA50). In increase in AR protein degradation. These open-label phase I ARMOR2 part 1, across all doses, PSA30 was 64.0% (16/25) and and II studies [Androgen Receptor Modulation Optimized PSA50 was 48.0% (12/25). In the 2,550-mg dose cohort, PSA30 for Response-1 (ARMOR1) and ARMOR2 part 1] evaluated was 72.7% (8/11) and PSA50 was 54.5% (6/11). Galeterone was the efficacy and safety of galeterone in patients with treat- well tolerated; the most common adverse events were fatigue, ment-naive nonmetastatic or metastatic castration-resistant increased liver enzymes, gastrointestinal events, and pruritus. Most prostate cancer (CRPC) and established a dose for further were mild or moderate in severity and required no action and there study. were no apparent mineralocorticoid excess (AME) events.
  • Companion Plants for Better Yields

    Companion Plants for Better Yields

    Companion Plants for Better Yields PLANT COMPATIBLE INCOMPATIBLE Angelica Dill Anise Coriander Carrot Black Walnut Tree, Apple Hawthorn Basil, Carrot, Parsley, Asparagus Tomato Azalea Black Walnut Tree Barberry Rye Barley Lettuce Beans, Broccoli, Brussels Sprouts, Cabbage, Basil Cauliflower, Collard, Kale, Rue Marigold, Pepper, Tomato Borage, Broccoli, Cabbage, Carrot, Celery, Chinese Cabbage, Corn, Collard, Cucumber, Eggplant, Irish Potato, Beet, Chive, Garlic, Onion, Beans, Bush Larkspur, Lettuce, Pepper Marigold, Mint, Pea, Radish, Rosemary, Savory, Strawberry, Sunflower, Tansy Basil, Borage, Broccoli, Carrot, Chinese Cabbage, Corn, Collard, Cucumber, Eggplant, Beet, Garlic, Onion, Beans, Pole Lettuce, Marigold, Mint, Kohlrabi Pea, Radish, Rosemary, Savory, Strawberry, Sunflower, Tansy Bush Beans, Cabbage, Beets Delphinium, Onion, Pole Beans Larkspur, Lettuce, Sage PLANT COMPATIBLE INCOMPATIBLE Beans, Squash, Borage Strawberry, Tomato Blackberry Tansy Basil, Beans, Cucumber, Dill, Garlic, Hyssop, Lettuce, Marigold, Mint, Broccoli Nasturtium, Onion, Grapes, Lettuce, Rue Potato, Radish, Rosemary, Sage, Thyme, Tomato Basil, Beans, Dill, Garlic, Hyssop, Lettuce, Mint, Brussels Sprouts Grapes, Rue Onion, Rosemary, Sage, Thyme Basil, Beets, Bush Beans, Chamomile, Celery, Chard, Dill, Garlic, Grapes, Hyssop, Larkspur, Lettuce, Cabbage Grapes, Rue Marigold, Mint, Nasturtium, Onion, Rosemary, Rue, Sage, Southernwood, Spinach, Thyme, Tomato Plant throughout garden Caraway Carrot, Dill to loosen soil Beans, Chive, Delphinium, Pea, Larkspur, Lettuce,
  • Tanibirumab (CUI C3490677) Add to Cart

    Tanibirumab (CUI C3490677) Add to Cart

    5/17/2018 NCI Metathesaurus Contains Exact Match Begins With Name Code Property Relationship Source ALL Advanced Search NCIm Version: 201706 Version 2.8 (using LexEVS 6.5) Home | NCIt Hierarchy | Sources | Help Suggest changes to this concept Tanibirumab (CUI C3490677) Add to Cart Table of Contents Terms & Properties Synonym Details Relationships By Source Terms & Properties Concept Unique Identifier (CUI): C3490677 NCI Thesaurus Code: C102877 (see NCI Thesaurus info) Semantic Type: Immunologic Factor Semantic Type: Amino Acid, Peptide, or Protein Semantic Type: Pharmacologic Substance NCIt Definition: A fully human monoclonal antibody targeting the vascular endothelial growth factor receptor 2 (VEGFR2), with potential antiangiogenic activity. Upon administration, tanibirumab specifically binds to VEGFR2, thereby preventing the binding of its ligand VEGF. This may result in the inhibition of tumor angiogenesis and a decrease in tumor nutrient supply. VEGFR2 is a pro-angiogenic growth factor receptor tyrosine kinase expressed by endothelial cells, while VEGF is overexpressed in many tumors and is correlated to tumor progression. PDQ Definition: A fully human monoclonal antibody targeting the vascular endothelial growth factor receptor 2 (VEGFR2), with potential antiangiogenic activity. Upon administration, tanibirumab specifically binds to VEGFR2, thereby preventing the binding of its ligand VEGF. This may result in the inhibition of tumor angiogenesis and a decrease in tumor nutrient supply. VEGFR2 is a pro-angiogenic growth factor receptor
  • Mechanisms of Toxic Action of the Flavonoid Quercetin and Its Phase II Metabolites

    Mechanisms of Toxic Action of the Flavonoid Quercetin and Its Phase II Metabolites

    Mechanisms of toxic action of the flavonoid quercetin and its phase II metabolites Hester van der Woude Promotor: Prof. Dr. Ir. I.M.C.M. Rietjens Hoogleraar in de Toxicologie Wageningen Universiteit Co-promotor: Dr. G.M. Alink Universitair Hoofddocent, Sectie Toxicologie Wageningen Universiteit. Promotiecommissie: Prof. Dr. A. Bast Universiteit Maastricht Dr. Ir. P.C.H. Hollman RIKILT Instituut voor Voedselveiligheid, Wageningen Prof. Dr. Ir. F.J. Kok Wageningen Universiteit Prof. Dr. T. Walle Medical University of South Carolina, Charleston, SC, USA Dit onderzoek is uitgevoerd binnen de onderzoekschool VLAG Mechanisms of toxic action of the flavonoid quercetin and its phase II metabolites Hester van der Woude Proefschrift ter verkrijging van de graad van doctor op gezag van de rector magnificus van Wageningen Universiteit, Prof. Dr. M.J. Kropff, in het openbaar te verdedigen op vrijdag 7 april 2006 des namiddags te half twee in de Aula Title Mechanisms of toxic action of the flavonoid quercetin and its phase II metabolites Author Hester van der Woude Thesis Wageningen University, Wageningen, the Netherlands (2006) with abstract, with references, with summary in Dutch. ISBN 90-8504-349-2 Abstract During and after absorption in the intestine, quercetin is extensively metabolised by the phase II biotransformation system. Because the biological activity of flavonoids is dependent on the number and position of free hydroxyl groups, a first objective of this thesis was to investigate the consequences of phase II metabolism of quercetin for its biological activity. For this purpose, a set of analysis methods comprising HPLC-DAD, LC-MS and 1H NMR proved to be a useful tool in the identification of the phase II metabolite pattern of quercetin in various biological systems.
  • Download Product Insert (PDF)

    Download Product Insert (PDF)

    Product Information Galeterone Item No. 17586 N CAS Registry No.: 851983-85-2 Formal Name: 17-(1H-benzimidazol-1-yl)-androsta- 5,16-dien-3β-ol N Synonym: TOK-001 MF: C26H32N2O FW: 388.6 H Purity: ≥98% H H Stability: ≥2 years at -20°C Supplied as: A crystalline solid HO Laboratory Procedures For long term storage, we suggest that galeterone be stored as supplied at -20°C. It should be stable for at least two years. Galeterone is supplied as a crystalline solid. A stock solution may be made by dissolving the galeterone in the solvent of choice. Galeterone is soluble in organic solvents such as ethanol, DMSO, and dimethyl formamide (DMF), which should be purged with an inert gas. The solubility of galeterone in ethanol and DMSO is approximately 20 mg/ml and approximately 30 mg/ml in DMF. Galeterone is sparingly soluble in aqueous buffers. For maximum solubility in aqueous buffers, galeterone should first be dissolved in DMF and then diluted with the aqueous buffer of choice. Galeterone has a solubility of approximately 0.2 mg/ml in a 1:3 solution of DMF:PBS (pH 7.2) using this method. We do not recommend storing the aqueous solution for more than one day. The cytochrome P450 (CYP) isoform CYP17 is also known as steroid 17α-hydroxylase/17,20 lyase because it catalyzes both 17α-hydroxylase and 17,20 lyase reactions in the synthesis of steroids, including androgens, estrogens, glucocorticoids, 1 and mineralocorticoids. Galeterone is a CYP17 inhibitor (IC50 = 300 nM) that has been shown to competitively block synthetic androgen binding (EC50 = 845 nM) and to antagonize the androgen receptor in transcriptional activation 2 assays.
  • Note: the Letters 'F' and 'T' Following the Locators Refers to Figures and Tables

    Note: the Letters 'F' and 'T' Following the Locators Refers to Figures and Tables

    Index Note: The letters ‘f’ and ‘t’ following the locators refers to figures and tables cited in the text. A Acyl-lipid desaturas, 455 AA, see Arachidonic acid (AA) Adenophostin A, 71, 72t aa, see Amino acid (aa) Adenosine 5-diphosphoribose, 65, 789 AACOCF3, see Arachidonyl trifluoromethyl Adlea, 651 ketone (AACOCF3) ADP, 4t, 10, 155, 597, 598f, 599, 602, 669, α1A-adrenoceptor antagonist prazosin, 711t, 814–815, 890 553 ADPKD, see Autosomal dominant polycystic aa 723–928 fragment, 19 kidney disease (ADPKD) aa 839–873 fragment, 17, 19 ADPKD-causing mutations Aβ, see Amyloid β-peptide (Aβ) PKD1 ABC protein, see ATP-binding cassette protein L4224P, 17 (ABC transporter) R4227X, 17 Abeele, F. V., 715 TRPP2 Abbott Laboratories, 645 E837X, 17 ACA, see N-(p-amylcinnamoyl)anthranilic R742X, 17 acid (ACA) R807X, 17 Acetaldehyde, 68t, 69 R872X, 17 Acetic acid-induced nociceptive response, ADPR, see ADP-ribose (ADPR) 50 ADP-ribose (ADPR), 99, 112–113, 113f, Acetylcholine-secreting sympathetic neuron, 380–382, 464, 534–536, 535f, 179 537f, 538, 711t, 712–713, Acetylsalicylic acid, 49t, 55 717, 770, 784, 789, 816–820, Acrolein, 67t, 69, 867, 971–972 885 Acrosome reaction, 125, 130, 301, 325, β-Adrenergic agonists, 740 578, 881–882, 885, 888–889, α2 Adrenoreceptor, 49t, 55, 188 891–895 Adult polycystic kidney disease (ADPKD), Actinopterigy, 223 1023 Activation gate, 485–486 Aframomum daniellii (aframodial), 46t, 52 Leu681, amino acid residue, 485–486 Aframomum melegueta (Melegueta pepper), Tyr671, ion pathway, 486 45t, 51, 70 Acute myeloid leukaemia and myelodysplastic Agelenopsis aperta (American funnel web syndrome (AML/MDS), 949 spider), 48t, 54 Acylated phloroglucinol hyperforin, 71 Agonist-dependent vasorelaxation, 378 Acylation, 96 Ahern, G.
  • Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr

    Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr

    Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Crizotinib (PF-02341066) 1 4 55 Docetaxel 1 5 98 Anastrozole 1 6 25 Cladribine 1 7 23 Methotrexate 1 8 -187 Letrozole 1 9 65 Entecavir Hydrate 1 10 48 Roxadustat (FG-4592) 1 11 19 Imatinib Mesylate (STI571) 1 12 0 Sunitinib Malate 1 13 34 Vismodegib (GDC-0449) 1 14 64 Paclitaxel 1 15 89 Aprepitant 1 16 94 Decitabine 1 17 -79 Bendamustine HCl 1 18 19 Temozolomide 1 19 -111 Nepafenac 1 20 24 Nintedanib (BIBF 1120) 1 21 -43 Lapatinib (GW-572016) Ditosylate 1 22 88 Temsirolimus (CCI-779, NSC 683864) 1 23 96 Belinostat (PXD101) 1 24 46 Capecitabine 1 25 19 Bicalutamide 1 26 83 Dutasteride 1 27 68 Epirubicin HCl 1 28 -59 Tamoxifen 1 29 30 Rufinamide 1 30 96 Afatinib (BIBW2992) 1 31 -54 Lenalidomide (CC-5013) 1 32 19 Vorinostat (SAHA, MK0683) 1 33 38 Rucaparib (AG-014699,PF-01367338) phosphate1 34 14 Lenvatinib (E7080) 1 35 80 Fulvestrant 1 36 76 Melatonin 1 37 15 Etoposide 1 38 -69 Vincristine sulfate 1 39 61 Posaconazole 1 40 97 Bortezomib (PS-341) 1 41 71 Panobinostat (LBH589) 1 42 41 Entinostat (MS-275) 1 43 26 Cabozantinib (XL184, BMS-907351) 1 44 79 Valproic acid sodium salt (Sodium valproate) 1 45 7 Raltitrexed 1 46 39 Bisoprolol fumarate 1 47 -23 Raloxifene HCl 1 48 97 Agomelatine 1 49 35 Prasugrel 1 50 -24 Bosutinib (SKI-606) 1 51 85 Nilotinib (AMN-107) 1 52 99 Enzastaurin (LY317615) 1 53 -12 Everolimus (RAD001) 1 54 94 Regorafenib (BAY 73-4506) 1 55 24 Thalidomide 1 56 40 Tivozanib (AV-951) 1 57 86 Fludarabine
  • Chapter 1 Definitions and Classifications for Fruit and Vegetables

    Chapter 1 Definitions and Classifications for Fruit and Vegetables

    Chapter 1 Definitions and classifications for fruit and vegetables In the broadest sense, the botani- Botanical and culinary cal term vegetable refers to any plant, definitions edible or not, including trees, bushes, vines and vascular plants, and Botanical definitions distinguishes plant material from ani- Broadly, the botanical term fruit refers mal material and from inorganic to the mature ovary of a plant, matter. There are two slightly different including its seeds, covering and botanical definitions for the term any closely connected tissue, without vegetable as it relates to food. any consideration of whether these According to one, a vegetable is a are edible. As related to food, the plant cultivated for its edible part(s); IT botanical term fruit refers to the edible M according to the other, a vegetable is part of a plant that consists of the the edible part(s) of a plant, such as seeds and surrounding tissues. This the stems and stalk (celery), root includes fleshy fruits (such as blue- (carrot), tuber (potato), bulb (onion), berries, cantaloupe, poach, pumpkin, leaves (spinach, lettuce), flower (globe tomato) and dry fruits, where the artichoke), fruit (apple, cucumber, ripened ovary wall becomes papery, pumpkin, strawberries, tomato) or leathery, or woody as with cereal seeds (beans, peas). The latter grains, pulses (mature beans and definition includes fruits as a subset of peas) and nuts. vegetables. Definition of fruit and vegetables applicable in epidemiological studies, Fruit and vegetables Edible plant foods excluding
  • Natuurlijke Bèta-2-Agonisten in Sportsupplementen

    Natuurlijke Bèta-2-Agonisten in Sportsupplementen

    Natuurlijke bèta-2-agonisten in sportsupplementen FATIMA DEN OUDEN, WILLEM KOERT | In de gereguleerde sport is het gebruik van bèta-2-agonisten slechts onder strikte voorwaar- den toegestaan. Bèta-2-agonisten kunnen de zuurstofopname en spiermassa van atleten vergroten en hun vetmassa verminderen. Hoewel bèta-2-agonisten officieel alleen op recept verkrijgbaar zijn, zijn er aanwijzingen dat de sportsup- plementenindustrie natuurlijke stoffen met een bèta-2-adrenergene werking is gaan toepassen in bepaalde producten. Dit artikel vat samen om welke stoffen het gaat, en wat er in de wetenschappelijke literatuur over hun werking bekend is. Volgens studies gebruikt veertig tot tachtig de stof de pompfunctie van het hart [6] en natuurlijke stoffen die volgens studies de procent van de topsporters en fitnessfana- laat het de concentratie vrije vetzuren in bèta-2-adrenoceptor stimuleren. Supple- ten supplementen die sportprestaties zou- het bloed stijgen en het energieverbruik mentenproducenten combineren deze den moeten verbeteren, en veel van deze toenemen [7]. Voeg daar nog aan toe dat stoffen vaak met cafeïne [12], een milde sti- producten bevatten plantenextracten. In higenamine volgens in vitro-studies de mulerende verbinding die de biologische dit segment is de scheidslijn tussen food luchtwegen kan verwijden [8], en het is dui- effecten van bèta-2-agonisten versterkt[13] . en pharma vervaagd, onder meer doordat delijk waarom het misschien een interes- Een van deze natuurlijke stoffen staat al op sommige supplementen natuurlijke stof- sante stof voor sporters is. Maar uit de stu- de dopinglijst van de WADA. Dat is octop- fen bevatten in zulke hoge concentraties dies wordt ook duidelijk dat higenamine amine, een stof die onder meer in bittere dat het predicaat ‘natuurlijk’ discutabel bijwerkingen kan hebben, zoals hartklop- sinaasappel (Citrus x aurantium L.) voorkomt is geworden.